Recovery From Schizophrenia: Psychiatry And Political Economy

NOTES 36547 Personal communication, Julian Leff.48 Pyke-Lees, P., “The National Schizophrenia Fellowship,” in Wing and Morris,Handbook of Psychiatric Rehabilitation, pp. 126–9.49 Geller, J.L., Brown, J.-M., Fisher, W.H. et al., “A national survey of ‘consumerempowerment’ at the state level,” Psychiatric Services, 49:498–503, 1998.50 Jones, L., “A Matter of Community II” Denver, Colorado: Capitol Hill Action andRecreation Group.51 Sherman, P.S. and Porter, R., “Mental health consumers as case managementaides,” Hospital and Community Psychiatry, 42:494–8, 1991.52 Warner, R. and Polak, P., “An economic development approach to the mentally illin the community,” Washington, DC: NIMH Community Support Programdocument, 1993.53 Lecomte, T., Wilde, J.B. and Wallace, C.J. “Mental health consumers as peerinterviewers,” Psychiatric Services, 50:693–5, 1999.54 Ekdawi, M.K., “The role of day units in rehabilitation,” in Wing and Morris,Handbook of Psychiatric Rehabilitation, pp. 95–8. The quotation is from p. 98.55 Beard, J.H., Propst, R. and Malamud, T.J., “The Fountain House model ofpsychiatric rehabilitation,” Psychosocial Rehabilitation Journal, 5:47–53, 1982.56 Warner, R., Huxley, P. and Berg, T., “An evaluation of the impact ofclubhouse membership on quality of life and treatment utilization,” InternationalJournal of Social Psychiatry, 45:310–20, 1999.57 Hasher, R., “Spiritmenders: A client-operated community center,” presented atAmerican Psychiatric Association annual meeting, San Francisco, May 6–11, 1989.58 McGorry, P.D. and Jackson, H.J., The Recognition and Management of Early Psychosis,Cambridge University Press, Cambridge, 1999; McGlashan, T.H., Miller, T.J. andWoods, S.W., “Pre-onset detection and intervention researching schizophreniapsychoses: Current estimates of benefit and risk,” Schizophrenia Bulletin, 27:563–70,2001.59 Crow, T.J., MacMillan, J.F., Johnson, A.L., and Johnstone, E.C., “A randomizedcontrolled trial of prophylactic neuroleptic treatment,” British Journal of Psychiatry,148:120–7, 1986.60 Jones, P.B., Bebbington, P., Foerster, A. et al., “Premorbid socialunderachievement in schizophrenia: Results of the Camberwell CollaborativePsychosis Study,” British Journal of Psychiatry, 162:65–71, 1993.61 Wyatt, R.J., Green, M.F. and Tuma, A.H., “Long-term morbidity associated withdelayed treatment of first admission schizophrenic patients,” Psychological Medicine,27:261–8, 1997.62 Moscarelli, M., Capri, S. and Neri, L., “Cost evaluation of chronic schizophrenicpatients during the first three years after the first contact,” Schizophrenia Bulletin, 17:421–6, 1991.63 Haas, G.L., Garrett, L.S. and Sweeney, J.A., “Delay to first antipsychotic medicationin schizophrenia: Impact on symptomatology and clinical course of illness,” Journal ofPsychiatric Research, 32:151–9, 1998; Helgason, L., “Twenty years’ follow-up of firstpsychiatric presentation for schizophrenia: What could have been prevented?” ActaPsychiatrica Scandinavica, 81:231–5, 1990.64 Loebel, A.D., Lieberman, J.A., Alvir, J.M.J. et al., “Duration of psychosis andoutcome in first-episode schizophrenia,” American Journal of Psychiatry, 149: 1183–8,1992; McGorry, P.D., Edwards, J., Mihalopoulos, C. et al., “EPPIC: An evolving